Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human …
R Elisei, M Schlumberger, A Driedger… - The Journal of …, 2009 - academic.oup.com
Background: We previously demonstrated comparable thyroid remnant ablation rates in
postoperative low-risk thyroid cancer patients prepared for administration of 3.7 GBq 131I …
postoperative low-risk thyroid cancer patients prepared for administration of 3.7 GBq 131I …
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk …
M Chianelli, V Todino, FM Graziano… - European Journal of …, 2009 - academic.oup.com
Objective (a) To compare the efficacy of low-activity (2 GBq; 54 mCi) 131I ablation using l-
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …
Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or …
E Molinaro, C Giani, L Agate, A Biagini… - The Journal of …, 2013 - academic.oup.com
Background: No long-term follow-up data are available for differentiated thyroid carcinoma
(DTC) patients prepared with either exogenous or endogenous TSH and treated with low …
(DTC) patients prepared with either exogenous or endogenous TSH and treated with low …
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible …
D Barbaro, G Boni, G Meucci, U Simi… - The Journal of …, 2003 - academic.oup.com
The main steps in the management of differentiated thyroid cancer are thyroidectomy,
treatment with iodine-131 (131I), and follow-up with whole-body scanning (WBS) and serum …
treatment with iodine-131 (131I), and follow-up with whole-body scanning (WBS) and serum …
A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant …
T Pilli, E Brianzoni, F Capoccetti… - The Journal of …, 2007 - academic.oup.com
Objective: Recently, a multicenter study in differentiated thyroid cancer (DTC) patients
showed that 3700 MBq 131-iodine (131I) after recombinant human TSH (rhTSH) had a …
showed that 3700 MBq 131-iodine (131I) after recombinant human TSH (rhTSH) had a …
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international …
F Pacini, PW Ladenson, M Schlumberger… - The Journal of …, 2006 - academic.oup.com
Context: After surgery for differentiated thyroid carcinoma, many patients are treated with
radioiodine to ablate remnant thyroid tissue. This procedure has been performed with the …
radioiodine to ablate remnant thyroid tissue. This procedure has been performed with the …
Recombinant human TSH–assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone …
RM Tuttle, M Brokhin, G Omry… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Recent studies have confirmed that radioactive iodine therapy after recombinant human
TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no …
TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no …
Recombinant human thyrotropin in thyroid remnant ablation with 131-iodine in high-risk patients
PW Rosario, ACM Xavier, MR Calsolari - Thyroid, 2010 - liebertpub.com
Background: Most patients with well-differentiated thyroid cancer (WDTC) are first treated by
total thyroidectomy followed by remnant ablation (RA) with 131I. There are less data …
total thyroidectomy followed by remnant ablation (RA) with 131I. There are less data …
Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide …
D Barbaro, M Grosso, G Boni, P Lapi… - European journal of …, 2010 - Springer
Background and aim Recombinant human TSH (rhTSH) can be used for post-surgical
radioiodine (I-131) thyroid remnants ablation in differentiated thyroid cancer (DTC) patients …
radioiodine (I-131) thyroid remnants ablation in differentiated thyroid cancer (DTC) patients …
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin
RJ Robbins, RM Tuttle, M Sonenberg, A Shaha… - Thyroid, 2001 - liebertpub.com
Radioiodine ablation (RA) of normal thyroid remnants after thyroidectomy for differentiated
thyroid carcinoma improves the sensitivity of subsequent radioiodine scans and serum …
thyroid carcinoma improves the sensitivity of subsequent radioiodine scans and serum …